Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 4
2004 7
2005 2
2006 8
2007 4
2008 9
2009 9
2010 6
2011 4
2012 5
2013 8
2014 5
2015 4
2016 3
2017 4
2018 3
2019 4
2020 2
2021 7
2022 13
2023 9
2024 1
2025 9
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
Dexmethylphenidate.
[No authors listed] [No authors listed] 2025 Aug 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2025 Aug 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999823 Free Books & Documents. Review.
Dexmethylphenidate is an isomer of methylphenidate. Methylphenidate levels in milk are low and not detectable in the serum of a few breastfed infants. If dexmethylphenidate is required by the mother, it is not a reason to discontinue breastfeeding.[1] It is possible
Dexmethylphenidate is an isomer of methylphenidate. Methylphenidate levels in milk are low and not detectable in the serum of a few b
Dexmethylphenidate.
Keating GM, Figgitt DP. Keating GM, et al. Drugs. 2002;62(13):1899-904; discussion 1905-8. doi: 10.2165/00003495-200262130-00009. Drugs. 2002. PMID: 12215063 Review.
Significantly fewer dexmethylphenidate than placebo recipients failed treatment in a double-blind, treatment-withdrawal trial in 75 children with ADHD (17.1 vs 61.5%). ...Dexmethylphenidate was generally well tolerated in children with ADHD; adverse events were cons …
Significantly fewer dexmethylphenidate than placebo recipients failed treatment in a double-blind, treatment-withdrawal trial in 75 c …
Drugs for ADHD.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2025 Sep 1;67(1736):137-144. doi: 10.58347/tml.2025.1736a. Med Lett Drugs Ther. 2025. PMID: 40839413 No abstract available.
Drugs for ADHD.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Jan 27;62(1590):9-15. Med Lett Drugs Ther. 2020. PMID: 31999670 Review. No abstract available.
Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials.
Nazarova VA, Sokolov AV, Chubarev VN, Tarasov VV, Schiöth HB. Nazarova VA, et al. Front Pharmacol. 2022 Nov 17;13:1066988. doi: 10.3389/fphar.2022.1066988. eCollection 2022. Front Pharmacol. 2022. PMID: 36467081 Free PMC article. Review.
The most common drug classes include central nervous system stimulants (e.g., methylphenidate hydrochloride, lisdexamfetamine dimesylate, amphetamine sulfate, mixed amphetamine salts, a combination of dexmethylphenidate hydrochloride and serdexmethylphenidate …
The most common drug classes include central nervous system stimulants (e.g., methylphenidate hydrochloride, lisdexamfetamine dimesyl …
Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder.
McGough JJ, Pataki CS, Suddath R. McGough JJ, et al. Expert Rev Neurother. 2005 Jul;5(4):437-41. doi: 10.1586/14737175.5.4.437. Expert Rev Neurother. 2005. PMID: 16026226 Review.
Dexmethylphenidate consists of the single dextro-isomer form of d,l-methylphenidate commonly marketed as Ritalin. Dexmethylphenidate extended release utilizes spheroidal oral drug absorption system technology to achieve a 50% immediate medication delivery and 50% de
Dexmethylphenidate consists of the single dextro-isomer form of d,l-methylphenidate commonly marketed as Ritalin. Dexmethylphenida
Dexmethylphenidate--Novartis/Celgene. Focalin, D-MPH, D-methylphenidate hydrochloride, D-methylphenidate, dexmethylphenidate, dexmethylphenidate hydrochloride.
[No authors listed] [No authors listed] Drugs R D. 2002;3(4):279-82. doi: 10.2165/00126839-200203040-00010. Drugs R D. 2002. PMID: 12455205 Review.
Celgene has developed a chirally pure form of methylphenidate (Ritalin), called dexmethylphenidate [d-methylphenidate, d-methylphenidate hydrochloride, d-MPH; Focalin]. The drug has been launched in the USA and is undergoing registration in Canada for the treatment …
Celgene has developed a chirally pure form of methylphenidate (Ritalin), called dexmethylphenidate [d-methylphenidate, d-methylphenid …
Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.
Sugrue D, Bogner R, Ehret MJ. Sugrue D, et al. Am J Health Syst Pharm. 2014 Jul 15;71(14):1163-70. doi: 10.2146/ajhp130638. Am J Health Syst Pharm. 2014. PMID: 24973373 Review.
PURPOSE: Current literature on the safety and efficacy of various intermediate- and long-acting preparations of methylphenidate and dexmethylphenidate for pediatric attention-deficit/hyperactivity disorder (ADHD) is reviewed. ...Methylphenidate and dexmethylphenidate
PURPOSE: Current literature on the safety and efficacy of various intermediate- and long-acting preparations of methylphenidate and dexme
Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder.
Moen MD, Keam SJ. Moen MD, et al. CNS Drugs. 2009 Dec;23(12):1057-83. doi: 10.2165/11201140-000000000-00000. CNS Drugs. 2009. PMID: 19958043 Review.
Dexmethylphenidate contains the d-threo-enantiomer of methylphenidate. Dexmethylphenidate XR capsules have a bimodal release profile, which mimics two doses of dexmethylphenidate immediate release (IR) given 4 hours apart, and allows once-daily administration
Dexmethylphenidate contains the d-threo-enantiomer of methylphenidate. Dexmethylphenidate XR capsules have a bimodal release p
133 results